Who doesn’t want to improve human health? Whether it’s reducing pain and inflammation from medical cannabis innovations or targeting cancer cells through personalized mRNA immunotherapy drugs, or novel insights into gut bacterial systems that increase our longevity. If you have a company or biomedical startup in this field, MIT and Harvard want you!
These universities are hosting a new prize, called the Richard N. Merkin Prize in Biomedical Technology and the winners will share $400,000 for their work.
The prize recognises novel technologies that have improved human health.
About the Merkin Family Foundation
The Merkin Family Foundation was founded by health care executive Dr. Richard Merkin, MD. Dr Merkin is the founder and chief executive officer of Heritage Provider Network and focuses his work and the bulk of his philanthropy on new paths to cures and to affordable, high-quality health care.
The prize will celebrate a novel technology and recognize up to four key contributors to the development of the technology, with a cash award of $400,000 to be shared among each year’s recipients. The winning technology must have made a demonstrable real-world impact on human health by improving the treatment, diagnosis, or prevention of disease.
The Merkin Prize is administered by the Broad Institute of MIT and Harvard, one of the world’s leading biomedical research institutes.
“The Merkin Prize will highlight the inventors of an important medical technology and will demonstrate how their work is transforming healthcare,” said Harold Varmus, a Nobel Prize winner for his work on the origins of cancer.
Eligibility for receipt of the Merkin Prize extends to all living investigators from anywhere in the world, using any discipline in academia, the commercial sector, or government. Anyone may submit a nomination, but self-nominations are not permitted.
Nominations must be submitted by Jan. 23, 2023
For further information visit merkinprize.org
If you want to submit a prize, dream job, or new company transforming the planet and healthcare, email us: [email protected]
